Health AI Central
Share:
Peer-Reviewed Publication
Cureus2025;17(3):e80422.March 1, 2025Journal Article

Area Deprivation Index and Coprescription of Opioids and Sedative Hypnotics.

Shelby Goicochea1, Amal Bhullar2, Scott Turner3, Benton J Stamper3, Christina Guerrier4, Raymond Pomm5, Kitty Leung2
1Psychiatry, Talkiatry, Jacksonville, USA.
2Psychiatry, University of Florida College of Medicine, Jacksonville, USA.
3Clinical Pharmacy, University of Florida College of Medicine, Jacksonville, USA.
4Epidemiology and Biostatistics, Protean Insights Partner, Jacksonville, USA.
5Psychiatry, Gateway Community Services, Jacksonville, USA.
PubMed PMC DOI PDF

Abstract

Background and objectives The coprescription of an opioid and a sedative-hypnotic (i.e., benzodiazepine or Z-drug) is associated with negative patient outcomes. Although multiple guidelines recommend minimizing this combination, studies demonstrate high coprescribing patterns. The Area Deprivation Index (ADI), a validated surrogate measure of socioeconomic status, was used to assess socioeconomic…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.